On this occasion Sachin Gupta, Chancellor Sanskriti University said “It is an happy occasion for all of us. The centre will provide quality classroom space to our faculty and staff, students along with researchers. This centre aimed to provide utility quality infrastructure, hi-Tech laboratories, to the students, teachers and researchers so that they can Contribute to the discovery and development of drugs that could potentially improve the health and well-being of millions of people.”
“We (The School of Pharmacy) engaged our research scholars and faculties for Patents. We have filed 304 patents including 3 international patents granted and ready for commercialization from 2020. Two scholars from School of Pharmacy Ms Deepti Mathpal Published three Pubmed articles and Ms Rinka Juneja published 3 UGC listed articles last month.” said Dr Tanmay Goswami Vice-Chancellor, Sanskriti University.
The Indian pharmaceuticals market is the third largest in terms of volume and thirteenth largest in terms of value, as per a report by Equity Master. India is the largest provider of generic drugs globally with the Indian generics accounting for 20 percent of global exports in terms of volume. Of late, consolidation has become an important characteristic of the Indian pharmaceutical market as the industry is highly fragmented.